Scientific

MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis

These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.

MK5 Proteome Analysis

Table 3: Type II network, divided ranks. This table presents the output of the simulation of a type-II network in which we relied on the high confidence interactions and micro-array results. The output of the micro-array was then ranked and these ranks used as input into the network simulation. After performing two such simulations (one for the MK5 off and one for the MK5 on microarray output), we divided the ranks and sorted the results accordingly. The output of this technique is a collection of proteins that cluster naturally together.


Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank Gene description Value Type Network Comparison Type Interaction Map Filtered red green network_comparison
Results: HTML CSV LaTeX Showing element 173 to 222 of 3228 in total 
Value Type: Measured
Network Comparison Type: Divided
Interaction Map: High confidence
Filtered: 1

\def\wcA{0.16666666666667\textwidth}
\def\wcB{0.16666666666667\textwidth}
\def\wcC{0.16666666666667\textwidth}
\def\wcD{0.16666666666667\textwidth}
\def\wcE{0.16666666666667\textwidth}
\begin{longtable}{|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
173\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
breast cancer antiestrogen resistance 3. [source:refseq;acc:nm\_003567]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4579.34\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5940.64\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.29727\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
174\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
mad protein (max dimerizer). [source:swissprot;acc:q05195]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4455.95\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5774.03\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.2958\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
175\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
max interacting protein 1 (mxi1 protein). [source:swissprot;acc:p50539]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4456.67\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5773.77\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.29553\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
176\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
max-interacting transcriptional repressor mad4 (max-associated protein 4) (max dimerization protein 4). [source:swissprot;acc:q14582]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4456.93\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5773.67\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.29544\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
177\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
max dimerization protein 3; likely ortholog of mouse max dimerization protein 3. [source:refseq;acc:nm\_031300]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4457.06\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5773.63\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.29539\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
178\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
myosin vb (myosin 5b) (fragment). [source:swissprot;acc:q9ulv0]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
21591.5\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
27904.5\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.29238\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
179\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
myosin vc (myosin 5c). [source:swissprot;acc:q9nqx4]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
180\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
myosin va (myosin 5a) (dilute myosin heavy chain, non-muscle) (myosin heavy chain 12) (myoxin). [source:swissprot;acc:q9y4i1]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
181\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
eukaryotic translation initiation factor 4 gamma, 3. [source:refseq;acc:nm\_003760]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4068.56\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5252.6\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.29102\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
182\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
rna-binding protein. [source:refseq;acc:nm\_019027]\vspace{3pt}}&\multirow{4}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
4069.83\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
5252.17\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.29051\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
183\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
apobec-1 complementation factor isoform 1; apobec-1 stimulating protein; apo-b rna editing protein. [source:refseq;acc:nm\_014576]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
184\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ns1-associated protein 1. [source:refseq;acc:nm\_006372]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
185\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
heterogeneous nuclear ribonucleoprotein r (hnrnp r). [source:swissprot;acc:o43390]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
186\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
eukaryotic translation initiation factor 4 gamma (eif-4-gamma) (eif- 4g) (eif4g) (p220). [source:swissprot;acc:q04637]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4071.1\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5251.75\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.29001\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
187\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
small nuclear ribonucleoprotein sm d3 (snrnp core protein d3) (sm-d3). [source:swissprot;acc:p43331]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4569.48\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5885.79\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.28807\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
188\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
source of immunodominant mhc-associated peptides; homolog of yeast stt3 gene. [source:refseq;acc:nm\_178862]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
4571.89\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
5864.86\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.28281\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
189\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
oligosaccharyl transferase stt3 subunit homolog (b5) (integral membrane protein 1) (tmc). [source:swissprot;acc:p46977]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
190\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
dolichyl-diphosphooligosaccharide--protein glycosyltransferase 48 kda subunit precursor (ec 2.4.1.119) (oligosaccharyl transferase 48 kda subunit) (ddost 48 kda subunit). [source:swissprot;acc:p39656]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
191\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
splicing factor 3b subunit 1 (spliceosome associated protein 155) (sap 155) (sf3b155) (pre-mrna splicing factor sf3b 155 kda subunit). [source:swissprot;acc:o75533]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4638.1\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5923.4\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.27712\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
192\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
a-raf proto-oncogene serine/threonine-protein kinase (ec 2.7.1.-) (a-raf-1) (proto-oncogene pks). [source:swissprot;acc:p10398]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
17757.5\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
14008\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.26767\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
193\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
raf proto-oncogene serine/threonine-protein kinase (ec 2.7.1.-) (raf-1) (c-raf). [source:swissprot;acc:p04049]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
17756.5\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
14007.3\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.26766\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
194\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
cyclin g2. [source:swissprot;acc:q16589]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
17738.6\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
13995.7\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.26743\vspace{3pt}}}\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
195\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
cyclin g1 (cyclin g). [source:swissprot;acc:p51959]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
17738.5\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
13995.6\vspace{3pt}}&\\\cline{1-2}\cline{4-5}
\parbox{\wcA}{\vspace{3pt}\noindent
196\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
serine/threonine protein phosphatase 2a, 56 kda regulatory subunit, epsilon isoform (pp2a, b subunit, b' epsilon isoform) (pp2a, b subunit, b56 epsilon isoform) (pp2a, b subunit, pr61 epsilon isoform) (pp2a, b subunit, r5 epsilon isoform). [source:swissprot;acc:q16537]\vspace{3pt}}&&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
13995.7\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.26742\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
197\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
serine/threonine protein phosphatase 2a, 56 kda regulatory subunit, alpha isoform (pp2a, b subunit, b' alpha isoform) (pp2a, b subunit, b56 alpha isoform) (pp2a, b subunit, pr61 alpha isoform) (pp2a, b subunit, r5 alpha isoform). [source:swissprot;acc:q15172]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
198\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
b-raf proto-oncogene serine/threonine-protein kinase (ec 2.7.1.-) (p94) (v-raf murine sarcoma viral oncogene homolog b1). [source:swissprot;acc:p15056]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
17710.9\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
13977.7\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.26708\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
199\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
serine/threonine protein phosphatase 2a, catalytic subunit, alpha isoform (ec 3.1.3.16) (pp2a-alpha) (replication protein c) (rp-c). [source:swissprot;acc:p05323]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4916.8\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
3888.18\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.26455\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
200\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
crk-associated substrate (p130cas) (breast cancer anti-estrogen resistance 1 protein). [source:swissprot;acc:p56945]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4808.79\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6074.21\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.26315\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
201\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
t-complex protein 1, delta subunit (tcp-1-delta) (cct-delta) (stimulator of tar rna binding). [source:swissprot;acc:p50991]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4810.22\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6075.04\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.26294\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
202\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
enhancer of filamentation 1 (hef1) (crk-associated substrate-related protein) (cas-l) (casl) (pp105) (neural precursor cell expressed developmentally down-regulated 9). [source:swissprot;acc:q14511]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4812.01\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
6076.09\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.26269\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
203\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
autophagy protein 12-like (apg12-like). [source:swissprot;acc:o94817]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
11757.8\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
9352.11\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.25723\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
204\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
small nuclear ribonucleoprotein e (snrnp-e) (sm protein e) (sm-e) (sme). [source:swissprot;acc:p08578]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
4512.19\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
5655.52\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.25339\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
205\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
small nuclear ribonucleoprotein f (snrnp-f) (sm protein f) (sm-f) (smf). [source:swissprot;acc:q15356]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
206\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
atlastin; guanylate-binding protein 3. [source:refseq;acc:nm\_015915]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
5720.25\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4577.5\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.24965\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
207\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
splicing factor 3b subunit 3 (spliceosome associated protein 130) (sap 130) (sf3b130) (pre-mrna splicing factor sf3b 130 kda subunit). [source:swissprot;acc:q15393]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4771.21\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5961.43\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.24946\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
208\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
voltage-dependent calcium channel gamma-8 subunit (neuronal voltage- gated calcium channel gamma-8 subunit). [source:swissprot;acc:q8wxs5]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
4068.78\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
5082.18\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.24907\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
209\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
voltage-dependent calcium channel gamma-3 subunit (neuronal voltage- gated calcium channel gamma-3 subunit). [source:swissprot;acc:o60359]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
210\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
voltage-dependent calcium channel gamma-2 subunit (neuronal voltage- gated calcium channel gamma-2 subunit). [source:swissprot;acc:q9y698]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4068.82\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5082.21\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.24906\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
211\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
voltage-dependent calcium channel gamma-4 subunit (neuronal voltage- gated calcium channel gamma-4 subunit). [source:swissprot;acc:q9ubn1]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4068.91\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5082.27\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.24905\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
212\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
transcription factor iiib 90 kda subunit (tfiiib90) (htfiiib90) (b- related factor 1) (hbrf) (tata box-binding protein-associated factor, rna polymerase iii, subunit 2) (taf3b2). [source:swissprot;acc:q92994]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
4446.72\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
5553.79\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.24896\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
213\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
nucleolar protein family a, member 1; gar1 protein. [source:refseq;acc:nm\_018983]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
214\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
voltage-dependent calcium channel gamma-5 subunit (neuronal voltage- gated calcium channel gamma-5 subunit). [source:swissprot;acc:q9uf02]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
4074.83\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5086.49\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.24827\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
215\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
transforming protein p21a (k-ras 2a) (ki-ras) (c-k-ras). [source:swissprot;acc:p01116]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
16074\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
12888.4\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.24717\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
216\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
leucine-rich repeat protein shoc-2 (ras-binding protein sur-8). [source:swissprot;acc:q9uq13]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
16071.6\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
12886.8\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.24714\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
217\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ral guanine nucleotide dissociation stimulator-like 2 (ralgds-like factor) (ras-associated protein rab2l). [source:swissprot;acc:o15211]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
218\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
transforming protein p21/h-ras-1 (c-h-ras). [source:swissprot;acc:p01112]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
16070.4\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
12886\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.24712\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
219\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
transforming protein n-ras. [source:swissprot;acc:p01111]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
16069.8\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
12885.6\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.24711\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
220\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
mannosyl-oligosaccharide 1,2-alpha-mannosidase ib (ec 3.2.1.113) (processing alpha-1,2-mannosidase ib) (alpha-1,2-mannosidase ib) (mannosidase alpha class 1a member 2). [source:swissprot;acc:o60476]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
41482.5\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
33356.5\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.24361\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
221\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
cytohesin 1 (sec7 homolog b2-1). [source:swissprot;acc:q15438]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
222\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
cytohesin 2 (arf nucleotide-binding site opener) (arno protein) (arf exchange factor). [source:swissprot;acc:q99418]\vspace{3pt}}&&&\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/